Tumor Markers

Tumor markers are substances that are produced by the body in cancerous conditions. Most tumor markers are made by both normal cells and cancer cells; however, they are produced at much higher levels in cancerous tissues. These markers can provide information to help diagnose cancer and predict or confirm patient response to cancer therapies. BTNX Inc. offers a selection of Rapid Response^TM brand tests to detect the presence of various tumor markers.

Tumor markers are measurable substances found in blood, urine, or tissue that can provide valuable insights into cancer-related conditions. These biomarkers are often present at low levels in healthy individuals but may increase when certain cancers develop. Healthcare professionals use them to support early detection strategies, monitor treatment response, and assess the likelihood of recurrence. While not used as a standalone diagnostic tool, tumor marker tests can help guide clinical decisions and enhance overall disease management.

BTNX Inc. offers a focused range of Rapid Response™ products designed for point-of-care and laboratory environments. Each diagnostic solution is developed to deliver reliable, quick results in simple-to-use formats such as cassettes and strips. These tests enable professionals to efficiently track key cancer indicators with minimal sample volumes. The availability of specific tests such as Alpha-Fetoprotein (AFP), Prostate-Specific Antigen (PSA), and Carcinoembryonic Antigen (CEA) supports a broad spectrum of diagnostic pathways. With consistent test quality and batch control, facilities can better ensure consistent results across patients.

Facilities seeking to maintain consistency in results can also benefit from using a tumor marker control kit, which supports internal quality assurance protocols. These kits are developed to complement our diagnostic tests and help minimize variability. Understanding how to test for tumor markers efficiently starts with having the right tools in place. All BTNX Inc. products in this category are manufactured to meet international quality standards and regulatory requirements, making them suitable for clinics, hospitals, and laboratories that prioritize both accuracy and turnaround time.

Clinicians and diagnostic facilities seeking a practical, reliable cancer marker test solution can rely on Rapid Response™ products for routine monitoring and follow-up. BTNX Inc. supports healthcare teams in delivering informed, timely care backed by dependable diagnostic tools.